Recent Posts
- GAVRETO™ (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson
- INQOVI (cedazuridine and decitabine), FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson
- Video Transcript: Optimizing Success for Community Physicians
- Video Transcript: Oral Therapy Adverse Events
- Video Transcript: Oral Oncolytics Versus Intravenous: Safety and Efficacy